|
Volumn 21, Issue 1, 2001, Pages 110-111
|
Atypical antipsychotics and cardiovascular risk in schizophrenic patients [2]
a a a b a c a b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
OLANZAPINE;
RISPERIDONE;
TRIACYLGLYCEROL;
VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ADULT;
BODY MASS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL ARTICLE;
CLINICAL TRIAL;
HUMAN;
HYPERINSULINEMIA;
LETTER;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
ADULT;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
BODY WEIGHT;
CARDIOVASCULAR DISEASES;
CROSS-SECTIONAL STUDIES;
HUMANS;
MALE;
PIRENZEPINE;
RISK FACTORS;
RISPERIDONE;
SCHIZOPHRENIA;
|
EID: 0035145342
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200102000-00021 Document Type: Letter |
Times cited : (29)
|
References (20)
|